Welcome to HitGen

Therapeutic Areas

Integrated One-stop Drug Discovery Platform   Accelerating Project with High Efficiency

  1. Therapeutic Areas
  2. Ophthalmology


HitGen has an industry-leading pipeline of targets addressing unmet needs in ophthalmology, such as glaucoma, ocular hypertension and wet age-related macular degeneration. By leveraging our DEL screening technology platform, our scientists has developed innovative candidates in preclinical stage for treating glaucoma disease.


Services for ophthalmology diseases drug discovery and development

  • Target Validation

  • Biochemical assays development

  • DEL Screening

  • Hit identification and generation

  • Hit-to-Lead

  • Lead optimization

  • Fragment-based drug discovery and structure-based drug discovery

  • Co-crystal structure generation and resolution

  • in vitro efficacy and ADME evaluation

  • in vivo pharmacology

  • Drug metabolism and pharmacokinetics (DMPK) 

  • Safety

  • IND submission

Thanks for reading!

For more details on how we can advance your innovative drug discovery projects
By submitting your information, you acknowledge having received, read and understood our Privacy Notice as made available above.

We use cookies to provide a better web experience.
By using our site, you acknowledge our use of cookies and please read our Cookie Notice for More information

XML 地图 | Sitemap 地图